CIBC Private Wealth Group
NVAX icon

CIBC Private Wealth Group’s Novavax NVAX Stock Holding History

CIBC Private Wealth Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$15.5K Buy
2,308
+995
+76% +$7.5K ﹤0.01% 2261
2025
Q3 		$11.4K Hold
1,313
– – ﹤0.01% 2343
2025
Q2 		$8.27K Sell
1,313
-995
-43% -$6.59K ﹤0.01% 2325
2025
Q1 		$14.6K Hold
2,308
– – ﹤0.01% 2105
2024
Q4 		$22.2K Hold
2,308
– – ﹤0.01% 2013
2024
Q3 		$29.1K Hold
2,308
– – ﹤0.01% 1993
2024
Q2 		$27.8K Buy
2,308
+2,000
+649% +$20.1K ﹤0.01% 1907
2024
Q1 		$1.43K Buy
+308
New +$1.43K ﹤0.01% 2811
2019
Q1 		– Sell
-3,500
Closed -$129K – 947
2018
Q4 		$129K Hold
3,500
– – ﹤0.01% 845
2018
Q3 		$132K Buy
+3,500
New +$98.6K ﹤0.01% 937

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return